David Wishart’s The Metabolomics Innovation Centre helped determine how COVID-19 affects different metabolites in an effort to build new tests and possibly create secondary therapeutics. (Photo: John Ulan)

Study identifies biomarkers that could be used in a quick, inexpensive COVID-19 blood screening tool

Posted on

How COVID-19 affects concentration of certain metabolites could also pinpoint who is most at-risk of death and even lead to a secondary therapy that could improve disease outcomes.

The concentration of specific metabolites in the blood could act as the foundation for a quick, inexpensive blood test that detects not only the presence of COVID-19 but which patients are at risk of becoming critically ill, according to a pan-Canadian study that included researchers from the University of Alberta….

https://www.folio.ca/study-identifies-biomarkers-that-could-be-used-in-a-quick-inexpensive-covid-19-blood-screening-tool/

Read More Impact Stories

Posted on
For patients with neuroblastoma, one of the most common solid tumours in children, disease outcomes can vary widely. Some children [...]
Posted on
McMaster researchers have developed the first COVID rapid test for community wastewater, which will make early warning surveillance of infectious [...]
Posted on
Study shows limited impact of pandemic on mental health, underlining strength of human resilience. COVID-19 has taken a relatively limited [...]